The effects of serine proteinase inhibitors on bone resorption in vitro

Journal of Endocrinology

Volumn 178, Issue 3, 2003, Pages 437-447

  Tumber, A ^a   Papaioannou, S ^a   Breckon, J ^a   Meikle, M C ^a   Reynolds, J J ^a   Hill, Peter A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN; ALPHA 2 ANTIPLASMIN; APROTININ; CALCIUM 45; COLLAGEN FIBRIL; COLLAGEN TYPE 1; CT 1399; ENZYME INHIBITOR; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEASE NEXIN I; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CULTURE; BONE MATRIX; BONE MINERALIZATION; BONE TISSUE; CALCIUM TRANSPORT; CALVARIA; CELL ACTIVITY; CELL AGGREGATION; CELL CULTURE; CELL FUSION; CELL ISOLATION; CELL MIGRATION; COLLAGEN DEGRADATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EXPLANT; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; IN SITU HYBRIDIZATION; IN VITRO STUDY; ISOTOPE LABELING; LONG BONE; METATARSAL BONE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOID; OSTEOLYSIS; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0141842614     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1780437     Document Type: Article

References (41)

1. 2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Journal of Cell Physiology 165 521-529.
2. Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA & Martin TJ 1991 Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Journal of Cell Physiology 149 34-43.
3. Baron R 1989 Molecular mechanisms of bone resorption by the osteoclast. Anatomical Record 224 317-324.
4. Bizik J, Lizonova A, Stephens RW, Grofova M & Vaheri A 1990 Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2 macroglobulin. Cell Regulation 1 895-905.
5. Blair HC, Teitelbaum SL, Ghiselli R & Gluck S 1989 Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245 855-857.
6. Blavier L & Delaisse JM 1995 Matrix metalloproteinases are obligatory for migration of preosteoclasts to the developing marrow cavity of primitive long bones. Journal of Cell Science 108 3649-3659.
7. Boyde A, Ali NN & Jones SJ 1984 Resorption of dentine by isolated osteoclasts in vitro. British Dental Journal 156 216-220.
8. Cajot JF, Schleuning WD, Medcalf RL, Bamat J, Testuz J, Liebermann L & Sordat B 1989 Mouse L cells expressing human prourokinase-type plasminogen activator: Effects on extracellular matrix degradation and invasion. Journal of Cell Biology 109 915-925.
9. Daci E, Udagawa N, Martin TJ, Bouillon R & Carmeliet G 1999 The role of the plasminogen system in bone resorption in vitro. Journal of Bone Mineral Research 14 946-952.
10. Delaisse JM & Vaes G 1992 Mechanisms of mineral solubilization and matrix degradation in osteoclastic bone resorption. In Biology and Physiology of the Osteoclast, pp 289-314. Eds BR Rifkin & CV Gay. Boca Raton: CRC Press.
11. Fukumoto S, Allan EH, Yee JA, Gelehrter TD & Martin TJ 1992 Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA. Journal of Cell Physiology 152 346-355.
12. Gavrilovic J, Reynolds JJ & Murphy G 1985 Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific inhibitor of metalloproteinases (TIMP). Cell Biology International Reports 9 1097-1107.
13. Grills BL, Gallagher JA, Allan EH, Yumita S & Martin TJ 1990 Identification of plasminogen activator in osteoclasts. Journal of Bone Mineral Research 5 499-505.
14. Hamilton JA, Lingelbach SR, Partridge NC & Martin TJ 1984 Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing agents. Biochemical and Biophysical Research Communications 122 230-235.
15. Hamilton JA, Lingelbach S, Partridge NC & Martin TJ 1985 Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts. Endocrinology 116 2186-2191.
16. Heath JK, Atkinson SJ, Meikle MC & Reynolds JJ 1984 Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochimica et Biophysica Acta 802 151-154.
17. Hill PA, Docherty AJP, Bottomley KMK, O'Connell JP, Morphy JR, Reynolds JJ & Meikle MC 1995 Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochemical Journal 308 167-175.
18. Hoekman K, Lowik CWGM, van de Ruit M, Bijvoet OLM, Verheijen JH & Papapoulos SE 1992 The effect of tissue type plasminogen activator on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA. Bone and Mineral 17 1-14.
19. Kirchheimer JC, Wojta J, Christ G & Binder BR 1987 Proliferation of a human epidermal tumor cell line stimulated by urokinase FASEB Journal 1 125-128.
20. Knudsen BS, Silverstein RL, Leung LL, Harpel PC & Nachman RL 1986 Binding of plasminogen to extracellular matrix. Journal of Biological Chemistry 261 10765-10771.
21. Kwaan HC 1992 The plasminogen-plasmin system in malignancy. Cancer Metastasis Review 11 291-311.
22. Lalou C, Silve C, Rosato R, Segovia B & Bonoux M 1994 Interactions between insulin-like growth factor-I and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein 3 production and proteolysis in human osteosarcoma cells. Endocrinology 135 2318-2326.
23. Leloup G, Delaisse JM & Vaes G 1994 Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bones. Journal of Bone Mineral Research 9 891-902.
24. Leloup G, Lemoine P, Carmeliet P & Vaes G 1996 Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor. Journal of Bone Mineral Research 11 1146-1157.
25. Martin TJ, Allan EH & Fukumoto S 1993 The plasminogen activator and inhibitor system in bone remodelling. Growth Regulation 3 209-214.
26. Meikle MC, Bord S, Hembry RM, Compston J, Croucher PI & Reynolds JJ 1992 Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines Journal of Cell Science 103 433-440.
27. Mignatti P & Rifkin DB 1993 Biology and biochemistry of proteinases in tumor invasion. Physiological Reviews 73 161-195.
28. Mignatti P, Robbins E & Rifkin DB 1986 Tumour invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47 487-498.
29. Murphy G & Knauper V 1997 Relating matrix metalloproteinase structure to function: why the hemopexin domain? Matrix Biology 15 511-518.
30. Murphy G, Ward R, Gavrilovic J & Atkinson S 1992 Physiological mechanisms for metalloproteinase activation. Matrix Supplement 1 224-230.
31. Quarles LD, Yohay DA, Lever LW, Caton R & Wenstrup RJ 1992 Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. Journal of Bone Mineral Research 7 683-692.
32. Quax PHA, Pedersen N, Masucci MT, Weening-Verhoeff EJD, Dano K, Verheijen JH & Blasi F 1991 Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. Cell Regulation 2 793-803.
33. Rabbani SA, Desjardins J, Bell AW, Banville D, Mazar A, Henkin J & Goltzman D 1990 An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochemical and Biophysical Research Communications 173 1058-1064.
34. Reynolds JJ & Dingle JT 1970 A sensitive in vitro method for studying the induction and inhibition of bone resorption. Calcified Tissue Research 4 339-349.
35. Ronday HK, Smits HH, Quax PH, van der Pluijm G, Lowik CW, Breedveld FC & Verheijen JH 1997 Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. British Journal of Rheumatology 36 9-15.
36. Stephens RW, Pollanen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Ronne E, Behrendt N, Dano K & Vaheri A 1989 Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface bound reactants Journal of Cell Biology 108 1987-1995.
37. Suda T, Takahashi N & Martin TJ 1992 Modulation of osteoclast differentiation. Endocrine Reviews 13 66-88.
38. 2 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123 1504-1510.
39. Thomson BM, Atkinson SJ, McGarrity AM, Hembry RM, Reynolds JJ & Meikle MC 1989 Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade. Biochimica et Biophysica Acta 1014 125-132.
40. Vassalli J-D, Sappino AP & Belin D 1991 The Plasminogen Activator/Plasminogen System. Journal of Clinical Investigation 88 1067-1072.
41. Yang JN, Allan EH, Anderson GI, Martin TJ & Minkin C 1997 Plasminogen activator system in osteoclasts. Journal of Bone Mineral Research 12 761-768.